SOPHiA GENETICS SA downgraded by Morgan Stanley with a new price target

8/7/24 11:39:17 AM ET

Biotechnology: Biological Products (No Diagnostic Substances)

Health Care

Morgan Stanley downgraded SOPHiA GENETICS SA from Overweight to Equal-Weight and set a new price target of $5.00 from $10.00 previously

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$SOPH

Date	Price Target	Rating	Analyst
12/18/2024	$11.00	Buy	Craig Hallum
8/7/2024	$10.00 → $5.00	Overweight → Equal-Weight	Morgan Stanley
6/27/2024	$6.00	Buy	Guggenheim
11/29/2023	$8.00	Outperform	RBC Capital Mkts
7/5/2023	$10.00	Overweight	JP Morgan
1/3/2023	$6.00	Buy	BTIG Research
11/23/2022	$2.00	Neutral	Credit Suisse
2/15/2022	$23.00 → $18.00	Overweight	Morgan Stanley